课题基金 / 基金详情

Characterisation of the C-type lectin receptor CLECSF8 (CLEC4D)

Characterisation of the C-type lectin receptor CLECSF8 (CLEC4D)
C 型凝集素受体 CLECSF8 (CLEC4D) 的表征
批准号:
MR/J004820/1
负责人:
Gordon Brown
金额:
$60.48万
依托单位:
依托单位国家:
英国
项目类别:
Research Grant
财政年份:
2012
资助国家:
英国
项目状态:
已结题
起止时间:
2012 至 --

项目摘要

项目成果

Gordon Brown的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Despite over a century of research, Mycobacterium tuberculosis remains one of the deadliest bacterial infections, resulting in over one and a half million deaths each year. Priorities to combat this global problem are the development of new antitubercular drugs and a more effective vaccine; both of which depend, in large part, on obtaining a better understanding of interactions between the host and this bacterial pathogen. We have identified a novel molecule (receptor) found on the surface of immune cells which appears to be involved in the control of M. tuberculosis during infection. Elucidating the functions of this receptor will provide substantial new insights into how the host combats these infections. To do this, we will make use of mouse models of infection by comparing normal mice to mice which lack this receptor. We will look at a variety of responses that may be influenced by the receptor, including how the host responds immediately upon infection (innate response) as well as responses later during infection, once the host has had time to recognise and respond specifically to M. tuberculosis (adaptive response). We will also look at the responses of individual cells to better understand how this receptor functions, such as inducing bacterial killing for example, and to determine what the receptor actually recognises on the mycobacteria, and the range of mycobacterial species that can be recognised. Another aspect of these studies, which we will address specifically, is the possibility that our receptor may provide insights for the development of more effective vaccines. Although much of our work will be performed using mouse models, we will also relate our findings to the human system, by showing that the human receptor functions in a similar manner in human cells. In addition, we will also examine the effect of various receptor polymorphisms; small genetic changes in the gene encoding the receptor which may have a significant effect on the receptors function. If we do find such influences, then ultimately we will explore the possibility of an association of these polymorphisms with alterations in disease susceptibility in human populations. We also have evidence that this receptor mediates its cellular functions through a novel mechanism. This mechanism involves transmitting information from the surface to the inside of the cell (intracellular signalling), and is critical for receptor function. Interestingly, we have evidence that our receptor does not transmit the intracellular signal directly, but rather associates with another molecule (an adaptor), which mediates this function. We wish to identify this adaptor molecule, which we will achieve using several different approaches, each of which involves established methodology. Once the adaptor is identified, then subsequent analysis will involve understanding its role in the receptor's function and in host immunity during mycobacterial infections. In sum, we have identified a novel receptor involved in anti-mycobacterial immunity, and the experiments described here will provide substantial and definitive insights into the role and functions of this receptor in both mice and humans.
期刊论文(9)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1038/mi.2015.79
发表时间: 2016-03
期刊: Mucosal immunology
影响因子: 8
作者: [Drummond RA, Dambuza IM, Vautier S, Taylor JA, Reid DM, Bain CC, Underhill DM, Masopust D, Kaplan DH, Brown GD]
通讯作者: Brown GD
Cutting edge: Failure of antigen-specific CD4+ T cell recruitment to the kidney during systemic candidiasis.
最前沿:全身性念珠菌病期间抗原特异性 CD4+ T 细胞募集至肾脏失败。
DOI: 10.4049/jimmunol.1401675
发表时间: 2014-12-01
期刊: Journal of immunology (Baltimore, Md. : 1950)
影响因子: --
作者: [Drummond RA, Wallace C, Reid DM, Way SS, Kaplan DH, Brown GD]
通讯作者: Brown GD
DOI: 10.1371/journal.ppat.1003417
发表时间: 2013
期刊: PLoS pathogens
影响因子: 6.7
作者: [Drummond RA, Brown GD]
通讯作者: Brown GD
DOI: 10.1016/j.micinf.2016.03.007
发表时间: 2016-07
期刊: Microbes and infection
影响因子: 5.8
作者: [Kerscher B, Dambuza IM, Christofi M, Reid DM, Yamasaki S, Willment JA, Brown GD]
通讯作者: Brown GD
6
    Tackling Emerging Co-Infections
    • 批准号:
      MC_PC_21021
    • 项目类别:
      Intramural
    • 资助金额:
      $25.48万
    • 财政年份:
      2022
    • 负责人:
      Gordon Brown
    • 依托单位:
    Dectin-1-mediated suppression of protective anti-mycobacterial immunity
    • 批准号:
      MR/W025779/1
    • 项目类别:
      Research Grant
    • 资助金额:
      $77.46万
    • 财政年份:
      2022
    • 负责人:
      Gordon Brown
    • 依托单位:
    Medical Research Council Centre for Medical Mycology
    • 批准号:
      MR/V033417/1
    • 项目类别:
      Research Grant
    • 资助金额:
      $211.89万
    • 财政年份:
      2021
    • 负责人:
      Gordon Brown
    • 依托单位:
    MRC Centre for Medical Mycology
    • 批准号:
      MR/N006364/2
    • 项目类别:
      Research Grant
    • 资助金额:
      $151.31万
    • 财政年份:
      2019
    • 负责人:
      Gordon Brown
    • 依托单位:
    国内基金
    海外基金
    铋基邻近双金属位点Type B异质结光热催化合成氨机制研究
    • 批准号:
    • 项目类别:
      省市级项目
    • 资助金额:
      30.0万元
    • 批准年份:
      2024
    • 负责人:
      黎景卫
    • 依托单位:
    盐皮质激素受体抑制2型固有淋巴细胞活化加重心肌梗死后心室重构的作用机制
    • 批准号:
      82372202
    • 项目类别:
      面上项目
    • 资助金额:
      49.00万元
    • 批准年份:
      2023
    • 负责人:
      侯旭敏
    • 依托单位:
    损伤线粒体传递机制介导成纤维细胞/II型肺泡上皮细胞对话在支气管肺发育不良肺泡发育阻滞中的作用
    • 批准号:
      82371721
    • 项目类别:
      面上项目
    • 资助金额:
      49.00万元
    • 批准年份:
      2023
    • 负责人:
      王星云
    • 依托单位:
    GPSM1介导Ca2+循环-II型肌球蛋白网络调控脂肪产热及代谢稳态的机制研究
    • 批准号:
      82370879
    • 项目类别:
      面上项目
    • 资助金额:
      49.00万元
    • 批准年份:
      2023
    • 负责人:
      严婧
    • 依托单位: